NCT04504331 2026-02-12Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast CancerStanford UniversityPhase 1 Terminated4 enrolled 11 charts
NCT02693080 2023-11-22CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Metastases Treated With Stereotactic Ablative Radiation TherapyStanford UniversityPhase 1 Completed19 enrolled